BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17147813)

  • 21. Priority setting in guideline development: article 2 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Atkins D; Perez-Padilla R; Macnee W; Buist AS; Cruz AA;
    Proc Am Thorac Soc; 2012 Dec; 9(5):225-8. PubMed ID: 23256163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations.
    Schünemann HJ; Fretheim A; Oxman AD
    Health Res Policy Syst; 2006 Dec; 4():21. PubMed ID: 17147810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating values and consumer involvement in guidelines with the patient at the center: article 8 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Kelson M; Akl EA; Bastian H; Cluzeau F; Curtis JR; Guyatt G; Montori VM; Oliver S; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):262-8. PubMed ID: 23256169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conscious sedation guidance.
    Coulthard P
    Evid Based Dent; 2006; 7(4):90-1. PubMed ID: 17187034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Guyatt G; Akl EA; Oxman A; Wilson K; Puhan MA; Wilt T; Gutterman D; Woodhead M; Antman EM; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):256-61. PubMed ID: 23256168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for incorporating resource allocation and economic considerations: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Matchar DB; Mark DB
    Chest; 2008 Jun; 133(6 Suppl):132S-140S. PubMed ID: 18574263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qualitative Evidence Synthesis (QES) for Guidelines: Paper 3 - Using qualitative evidence syntheses to develop implementation considerations and inform implementation processes.
    Glenton C; Lewin S; Lawrie TA; Barreix M; Downe S; Finlayson KW; Tamrat T; Rosenbaum S; Tunçalp Ö
    Health Res Policy Syst; 2019 Aug; 17(1):74. PubMed ID: 31391071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving the use of research evidence in guideline development: 4. Managing conflicts of interests.
    Boyd EA; Bero LA
    Health Res Policy Syst; 2006 Dec; 4():16. PubMed ID: 17140441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporating economic analysis in evidence-based guidelines for mental health: the profile approach.
    Mason J; Eccles M; Freemantle N; Drummond M
    J Ment Health Policy Econ; 1999 Mar; 2(1):13-19. PubMed ID: 11967403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptation, evaluation, and updating of guidelines: article 14 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Burgers JS; Anzueto A; Black PN; Cruz AA; Fervers B; Graham ID; Metersky M; Woodhead M; Yawn BP;
    Proc Am Thorac Soc; 2012 Dec; 9(5):304-10. PubMed ID: 23256175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deciding what type of evidence and outcomes to include in guidelines: article 5 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Wilt TJ; Guyatt G; Kunz R; Macnee W; Puhan MA; Viegi G; Woodhead M; Akl EA; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):243-50. PubMed ID: 23256166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conducting systematic reviews of economic evaluations.
    Gomersall JS; Jadotte YT; Xue Y; Lockwood S; Riddle D; Preda A
    Int J Evid Based Healthc; 2015 Sep; 13(3):170-8. PubMed ID: 26288063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Most guideline organizations lack explicit guidance in how to incorporate cost considerations.
    Sanabria AJ; Kotzeva A; Selva Olid A; Pequeño S; Vernooij RWM; Martínez García L; Zhang Y; Solà I; Thornton J; Alonso-Coello P
    J Clin Epidemiol; 2019 Dec; 116():72-83. PubMed ID: 31430507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.